Assertio Holdings | DEPO - Ebit

Stock Price
19.39
Daily Change
-0.14 -0.72%
Monthly
64.74%
Yearly
86.88%
Q1 Forecast
18.01

Assertio Holdings reported $-3.94M in EBIT for its fiscal quarter ending in September of 2023.





Ebit Change Date
ANI Pharmaceuticals USD 29.13M 6.3M Dec/2025
Aurora Cannabis CAD -35.79M 8.96M Dec/2025
Cara Therapeutics USD -2.39M 3.16M Mar/2025
Daiichi Sankyo JPY 89.54B 42.01B Dec/2025
Ironwood Pharmaceuticals USD 33.22M 7.58M Dec/2024
J&J USD 5.11B 2.3B Dec/2025
Knight Therapeutics CAD 6.21M 3.27M Dec/2025
Merck USD 6.24B 1.32B Dec/2025
Nektar Therapeutics USD -34.34M 3.68M Sep/2024
Omeros USD -48.15M 7.25M Sep/2023
Pfizer USD 4.65B 71M Dec/2025
Teva Pharmaceutical Industries USD 577M 491M Dec/2025